Author: Christie HerreraPublisher:
ISBN: 9780982231531
Category : Drug reimportation
Languages : en
Pages : 24
Book Description
The State Legislators Guide to Prescription Drug Policy
Author: Christie HerreraPublisher:
ISBN: 9780982231531
Category : Drug reimportation
Languages : en
Pages : 24
Book Description
The State Legislators Desktop Reference to Prescription Drug Policy
Author: Merrill MatthewsPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 31
Book Description
The State Legislator's Guide to Medicare Prescription Drug Coverage
Author: American Legislative Exchange CouncilPublisher:
ISBN:
Category : Medicare
Languages : en
Pages : 21
Book Description
Prescription Drug Policy Options for Improving Access and Lowering State Costs Before the California Legislature
Author: Ramon CastellblanchPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 15
Book Description
The Medicare Handbook
Author: Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Regulating the practice of pharmacy
Author: CaliforniaHow Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
Author: Publisher: U.S. Government Printing Office
ISBN:
Category : Business & Economics
Languages : en
Pages : 94
Book Description
Quality and cost standards for drugs
Author: United States. Task Force on Prescription DrugsPublisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages : 34
Book Description